Panorama -Noninvasive Prenatal Testing (NIPT)
Panorama is a blood-based genetic, prenatal screening test of the pregnant person that screens for common chromosomal conditions that affect a baby’s health. Panorama uses SNP*-based technology to deliver highly accurate results and unique insights for both singleton and twin pregnancies. Panorama can be performed as early as nine weeks gestation. Most results will be returned to your doctor within 5-7 calendar days.
Panorama is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot know for sure if your baby has that condition based upon the screening result alone. All medical decisions should be made after discussion with your healthcare provider regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.
Panorama is:
- validated in the largest prospective NIPT study ever
- the only NIPT that distinguishes mother’s DNA from baby’s DNA
- the approach that creates unique, clinically validated capabilities
Panorama evaluates SNPs— the 1% of our DNA that makes us different from one another
- Validated in SMART, the largest prospective NIPT study with over 20,000 participants enrolled.
- More than 3 million people in more than 60 countries have chosen Panorama for genetic testing during pregnancy.
- Panorama has been evaluated in 25 peer-reviewed publications and in more than 1.3 million pregnancies.
- Panorama offers complimentary pre- and post-test information sessions with board-certified genetic counselors.
- Panorama is performed from a simple blood draw of the pregnant person and poses no risk to the pregnancy.
Panorama is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot know for sure if your baby has that condition based upon the screening result alone. All medical decisions should be made after discussion with your healthcare provider regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.
- Trisomy 21
- Trisomy 18
- Trisomy 13
- Sex chromosome trisomies (reported when seen)*
- 22Q11.2 deletion syndrome (optional)*
*Identical twins only